BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 251 filers reported holding BLUEBIRD BIO INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $436,000 | +2.6% | 13,629 | -3.3% | 0.00% | 0.0% |
| Q1 2021 | $425,000 | -20.6% | 14,099 | +14.0% | 0.00% | -33.3% |
| Q4 2020 | $535,000 | -50.9% | 12,364 | -38.8% | 0.00% | -57.1% |
| Q3 2020 | $1,089,000 | +73.1% | 20,193 | +96.1% | 0.01% | +40.0% |
| Q2 2020 | $629,000 | +42.0% | 10,298 | +6.9% | 0.01% | +25.0% |
| Q1 2020 | $443,000 | +71.7% | 9,633 | +487.4% | 0.00% | +100.0% |
| Q1 2019 | $258,000 | +7.9% | 1,640 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $239,000 | +2.6% | 1,640 | +20.2% | 0.00% | -33.3% |
| Q1 2018 | $233,000 | – | 1,364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 4,282,827 | $13,019,794 | 1.84% |
| Birchview Capital, LP | 455,200 | $1,383,808 | 1.18% |
| PFM Health Sciences, LP | 6,040,934 | $18,364,439 | 0.86% |
| Lion Point Capital, LP | 531,256 | $1,615,018 | 0.72% |
| Endurant Capital Management LP | 251,785 | $765,426 | 0.69% |
| Bleichroeder LP | 900,000 | $2,736,000 | 0.67% |
| Connacht Asset Management LP | 31,634 | $96,167 | 0.57% |
| Granahan Investment Management | 5,137,778 | $15,618,845 | 0.56% |
| Frazier Life Sciences Management, L.P. | 1,709,907 | $5,198,117 | 0.34% |
| Contrarius Investment Management Ltd | 1,308,002 | $3,976 | 0.22% |